Skip to Content
You are currently on the new version of our website. Access the old version .
  • Review
  • Open Access

29 April 2020

11 Pages

Arsenic Exposure and Risk of Urothelial Cancer: Systematic Review and Meta-Analysis

,
,
,
,
,
,
and
1
Department of Pharmacy, “G. d’Annunzio” University Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy
2
Department of Medicine and Aging Sciences, “G. d’Annunzio” University Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy
3
School of Hygiene and Preventive Medicine, “G. d’Annunzio” University Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy
4
Centre for Outcomes Research and Clinical Epidemiology (CORESEARCH), Via Tiziano Veciello, 65100 Pescara, Italy

Abstract

Background: Arsenic is a toxic metalloid element widely distributed throughout the environment. Arsenic contaminated water has become an ongoing public health issue affecting hundred million people worldwide. The aim of this paper was to summarize the evidence in the association between arsenic metabolites and urinary tract cancer risk. Methods: A systematic review was conducted searching for observational studies that evaluated the association of arsenic metabolites and urinary tract cancer. Risk estimates from individual studies were pooled by using random effects models. Results: All the metabolites considered in this study resulted to be significantly associated to urothelial cancer, respectively: IA% 3.51 (1.21–5.82) (p = 0.003), MMA with WMD = 2.77 (1.67–3.87) (p < 0.001) and DMA with WMD = −4.56 (−7.91–1.22) (p = 0.008). Conclusions: Arsenic metabolites are significantly associated to urothelial cancer. Future studies will help to verify the independent association(s) between arsenic metabolites and urothelial cancer.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.